Tissue Regenix Group PLC (LSE:TRX) - Share price - Overview

Stock Report

Tissue Regenix Group PLC TRX

Last Price
GBX10.00

Day Change
-0.50|-4.76%

As of 16/07/2018
08:42:56 BST | GBX
Minimum 15 Minutes Delay.

Last Close10.50p
Day Range10.00 - 10.00
Mkt Cap123.00Mil
52-Wk Range5.50 - 16.02
Yield %-
ISINGB00B5SGVL29
Volume1,000
P/E-11.16
P/S0.18
P/CF-0.09

Share Price

Total Returns 13/07/2018

 Chg (%)  
More ...
Tissue Regenix Group PLC-4.55 
FTSE 100 TR GBP-0.36
 
Financials
201520162017
More ...
Income Statement
Turnover0.10-5.23
Operating Profit-8.37-11.06-9.72
Net Profit-7.58-9.50-9.42
Reported EPS-1.19-1.27-1.00
Balance Sheet
Current Assets12.2422.3023.46
Non Current Assets0.440.9022.30
Total Assets12.6723.2045.76
Current Liabilities1.101.964.78
Total Liabilities1.101.966.24
Total Equity11.5821.2439.52
Cash Flow
Operating Cash Flow-8.29-8.88-9.79
Net Change in Cash-8.239.658.08
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/08/2017PurchaseMr. Jonathan M Glenn10.00600,00060,000.00
09/08/2017PurchaseMr. John Andrew Walter Samuel10.002,000,000200,000.00
09/08/2017PurchaseMr. Anthony Ruben Odell10.00150,00015,000.00
09/08/2017PurchaseMr. Steven Ashley Couldwell10.00300,00030,000.00

Company Profile

Tissue Regenix Group PLC is a biotechnology company. Its business includes the development of regenerative products using its dcell technology.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 28/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-23.71
Op Mrgn-1.86
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Alan Jonathan Richard Miller
Non-Executive DirectorMr. Jonathan M Glenn
Executive Director, Chief Executive OfficerMr. Steven Ashley Couldwell
Non-Executive DirectorProfessor Shervanthi Homer-Vanniasinkam
Executive Director, Group Finance Director and Company SecretaryMr. Paul John Devlin
Executive Director, ChairmanMr. John Andrew Walter Samuel
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.